Revvity
Revvity Expands Pact With Genomics England to Provide Sequencing Services for Newborn Study
Genomics England's Generation Study involves the screening of up to 100,000 newborns for more than 200 rare genetic disorders.
In Brief This Week: Singular Genomics, T2 Biosystems, Revvity, Agilent Technologies, Danaher, More
News items for the week of Feb. 17, 2025.
The company aims to soon launch two tests to aid the treatment of dermatomycosis and is developing other tests for healthcare-acquired infections and lung diseases.
Revvity Sees Possible Path to Higher Growth Rates in 2025 While Firm's Q4 Dx Revenues Rise 4 Percent
Premium
The firm reported that its full-year 2024 revenues were up slightly as a rise in the diagnostics business was mostly offset by a decline in life sciences business.
The small Baltimore-based lab is preparing for the possibility of additional appeals as years of litigation wind down.
Jan 14, 2025
Jan 7, 2025
Revvity Enters Into $1.5B Credit Facility
Oct 15, 2024
Barclays Upgrades Revvity to Overweight
Sep 18, 2024
Apr 1, 2024